Loading...

Francesca Torriani

TitleTeacher
InstitutionUniversity of California San Diego
Address200 W. Arbor Drive #8951
San Diego CA 92103
Phone619-543-8258
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Borok J, Udkoff J, Vaida F, Murphy J, Torriani F, Waldman A, Ahluwalia J, Eichenfield LF. Transforming acne care by pediatricians: An interventional cohort study. J Am Acad Dermatol. 2018 May 09. PMID: 29753064.
      View in: PubMed
    2. Cachay ER, Ballard C, Colwell B, Torriani F, Hicks C, Mathews WC. Validation of a questionnaire to monitor symptoms in HIV-infected patients during hepatitis C treatment. AIDS Res Ther. 2017 Sep 20; 14(1):56. PMID: 28931406.
      View in: PubMed
    3. King P, Pham LK, Waltz S, Sphar D, Yamamoto RT, Conrad D, Taplitz R, Torriani F, Forsyth RA. Correction: Longitudinal Metagenomic Analysis of Hospital Air Identifies Clinically Relevant Microbes. PLoS One. 2016; 11(12):e0169376. PMID: 28030605.
      View in: PubMed
    4. Chinn R, Lempp JM, Huang SS, Murthy R, Torriani F, Daley J, Dekker E, Goss-Bottorff B, Kaler W, Meyer K, Myers F, Nichols A, Birnbaum D. Standardized Infection Ratio for Surgical Site Infection after Colon Surgery: Discord in Models Measuring Healthcare Quality. Infect Control Hosp Epidemiol. 2016 11; 37(11):1378-1382. PMID: 27573521.
      View in: PubMed
    5. King P, Pham LK, Waltz S, Sphar D, Yamamoto RT, Conrad D, Taplitz R, Torriani F, Forsyth RA. Longitudinal Metagenomic Analysis of Hospital Air Identifies Clinically Relevant Microbes. PLoS One. 2016; 11(8):e0160124. PMID: 27482891; PMCID: PMC4970769.
    6. Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell J, Mangino JE, Weber DM, Hebert CL, Marzec NS, Barron MA, Chaparro-Rojas F, Restrepo A, Hemmige V, Prasidthrathsint K, Cobb S, Herwaldt L, Raabe V, Cannavino CR, Hines AG, Bares SH, Antiporta PB, Scardina T, Patel U, Reid G, Mohazabnia P, Kachhdiya S, Le BM, Park CJ, Ostrowsky B, Robicsek A, Smith BA, Schied J, Bhatti MM, Mayer S, Sikka M, Murphy-Aguilu I, Patwari P, Abeles SR, Torriani F, Abbas Z, Toya S, Doktor K, Chakrabarti A, Doblecki-Lewis S, Looney DJ, David MZ. Bacterial and viral co-infections complicating severe influenza: Incidence and impact among 507 U.S. patients, 2013-14. J Clin Virol. 2016 07; 80:12-9. PMID: 27130980.
      View in: PubMed
    7. Cachay ER, Wyles D, Hill L, Ballard C, Torriani F, Colwell B, Kuo A, Schooley R, Mathews CW. The Impact of Direct-Acting Antivirals in the Hepatitis C-Sustained Viral Response in Human Immunodeficiency Virus-Infected Patients With Ongoing Barriers to Care. Open Forum Infect Dis. 2015 Dec; 2(4):ofv168. PMID: 26697509; PMCID: PMC4683297.
    8. Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell J, Mangino JE, Weber DM, Hebert CL, Marzec NS, Barron MA, Chaparro-Rojas F, Restrepo A, Hemmige V, Prasidthrathsint K, Cobb S, Herwaldt L, Raabe V, Cannavino CR, Hines AG, Bares SH, Antiporta PB, Scardina T, Patel U, Reid G, Mohazabnia P, Kachhdiya S, Le BM, Park CJ, Ostrowsky B, Robicsek A, Smith BA, Schied J, Bhatti MM, Mayer S, Sikka M, Murphy-Aguilu I, Patwari P, Abeles SR, Torriani F, Abbas Z, Toya S, Doktor K, Chakrabarti A, Doblecki-Lewis S, Looney DJ, David MZ. Severe Influenza in 33 US Hospitals, 2013-2014: Complications and Risk Factors for Death in 507 Patients. Infect Control Hosp Epidemiol. 2015 Nov; 36(11):1251-60. PMID: 26224364.
      View in: PubMed
    9. Cachay ER, Hill L, Wyles D, Colwell B, Ballard C, Torriani F, Mathews WC. The hepatitis C cascade of care among HIV infected patients: a call to address ongoing barriers to care. PLoS One. 2014; 9(7):e102883. PMID: 25036553; PMCID: PMC4103859.
    10. Andrade RM, Torriani F, Ellis RJ. Acute HIV infection presenting as fulminant meningoencephalitis with massive CSF viral replication. Neurol Clin Pract. 2014 Jun; 4(3):256-259. PMID: 25110623.
      View in: PubMed
    11. Cachay ER, Wyles DL, Torriani F, Ballard C, Colwell B, Lin JC, Hill L, Mathews WC. High incidence of serious adverse events in HIV-infected patients treated with a telaprevir-based hepatitis C virus treatment regimen. AIDS. 2013 Nov 28; 27(18):2893-7. PMID: 23842130.
      View in: PubMed
    12. Hulgan T, Stein JH, Cotter BR, Murdock DG, Ritchie MD, Dube MP, Gerschenson M, Haas DW, Torriani F. Mitochondrial DNA variation and changes in adiponectin and endothelial function in HIV-infected adults after antiretroviral therapy initiation. AIDS Res Hum Retroviruses. 2013 Oct; 29(10):1293-9. PMID: 23944767; PMCID: PMC3785797.
    13. McLean JS, Lombardo MJ, Ziegler MG, Novotny M, Yee-Greenbaum J, Badger JH, Tesler G, Nurk S, Lesin V, Brami D, Hall AP, Edlund A, Allen LZ, Durkin S, Reed S, Torriani F, Nealson KH, Pevzner PA, Friedman R, Venter JC, Lasken RS. Genome of the pathogen Porphyromonas gingivalis recovered from a biofilm in a hospital sink using a high-throughput single-cell genomics platform. Genome Res. 2013 May; 23(5):867-77. PMID: 23564253; PMCID: PMC3638142.
    14. Cachay ER, Hill L, Ballard C, Colwell B, Torriani F, Wyles D, Mathews WC. Increasing Hepatitis C treatment uptake among HIV-infected patients using an HIV primary care model. AIDS Res Ther. 2013 Mar 28; 10(1):9. PMID: 23537147; PMCID: PMC3620560.
    15. Tehrani DM, Russell D, Brown J, Boynton-Delahanty K, Quan K, Gibbs L, Braddock G, Zaroda T, Koopman M, Thompson D, Nichols A, Cui E, Liu C, Cohen S, Rubin Z, Pegues D, Torriani F, Datta R, Huang SS. Discord among performance measures for central line-associated bloodstream infection. Infect Control Hosp Epidemiol. 2013 Feb; 34(2):176-83. PMID: 23295564.
      View in: PubMed
    16. Opravil M, Rodriguez-Torres M, Rockstroh J, Snoeck E, Chung RT, Tietz A, Torriani F. The dose-response relationship of peginterferon alfa-2a and ribavirin in the treatment of patients coinfected with HIV-HCV. HIV Clin Trials. 2012 Jan-Feb; 13(1):33-45. PMID: 22306586.
      View in: PubMed
    17. Cachay ER, Wyles DL, Goicoechea M, Torriani F, Ballard C, Colwell B, Gish RG, Mathews WC. Reliability and predictive validity of a hepatitis-related symptom inventory in HIV-infected individuals referred for Hepatitis C treatment. AIDS Res Ther. 2011 Aug 10; 8:29. PMID: 21831314; PMCID: PMC3163174.
    18. Murphy RL, Berzins B, Zala C, Fichtenbaum C, Dube MP, Guaraldi G, Torriani F, Belsey E, Mitchell C, Stein JH. Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy. AIDS. 2010 Mar 27; 24(6):885-90. PMID: 19952712.
      View in: PubMed
    19. Potenza B, Deligencia M, Estigoy B, Faraday E, Snyder A, Angle N, Schwartz A, Chang L, Hackett J, Minokadeh A, Madani M, MacAulay K, Ramamoorthy S, Blaner L, James C, Bansal V, Torriani F, Coimbra R. Lessons learned from the institution of the Surgical Care Improvement Project at a teaching medical center. Am J Surg. 2009 Dec; 198(6):881-8. PMID: 19969146.
      View in: PubMed
    20. Maragakis LL, Chaiwarith R, Srinivasan A, Torriani F, Avdic E, Lee A, Ross TR, Carroll KC, Perl TM. Sphingomonas paucimobilis bloodstream infections associated with contaminated intravenous fentanyl. Emerg Infect Dis. 2009 Jan; 15(1):12-8. PMID: 19116043; PMCID: PMC2660711.
    21. Stein JH, Komarow L, Cotter BR, Currier JS, Dubé MP, Fichtenbaum CJ, Gerschenson M, Mitchell CK, Murphy RL, Squires K, Parker RA, Torriani F. Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy. J Clin Lipidol. 2008 Dec; 2(6):464-471. PMID: 19956354.
      View in: PubMed
    22. Torriani F, Komarow L, Parker RA, Cotter BR, Currier JS, Dubé MP, Fichtenbaum CJ, Gerschenson M, Mitchell CK, Murphy RL, Squires K, Stein JH. Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. J Am Coll Cardiol. 2008 Aug 12; 52(7):569-76. PMID: 18687253; PMCID: PMC2603599.
    23. Opravil M, Sasadeusz J, Cooper DA, Rockstroh JK, Clumeck N, Clotet B, Montaner J, Torriani F, Depamphilis J, Dieterich DT. Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfection. J Acquir Immune Defic Syndr. 2008 Jan 01; 47(1):36-49. PMID: 18156990.
      View in: PubMed
    24. Dore GJ, Torriani F, Rodriguez-Torres M, Bräu N, Sulkowski M, Lamoglia RS, Tural C, Clumeck N, Nelson MR, Mendes-Correa MC, Godofsky EW, Dieterich DT, Yetzer E, Lissen E, Cooper DA. Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infection. AIDS. 2007 Jul 31; 21(12):1555-9. PMID: 17630550.
      View in: PubMed
    25. Currier JS, Kendall MA, Henry WK, Alston-Smith B, Torriani F, Tebas P, Li Y, Hodis HN. Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults. AIDS. 2007 May 31; 21(9):1137-45. PMID: 17502724.
      View in: PubMed
    26. Thompson K, Torriani F. Community-associated methicillin-resistant Staphylococcus aureus in the patient with HIV infection. Curr HIV/AIDS Rep. 2006 Sep; 3(3):107-12. PMID: 16970836.
      View in: PubMed
    27. Hornberger J, Torriani F, Dieterich DT, Bräu N, Sulkowski MS, Torres MR, Green J, Patel K. Cost-effectiveness of peginterferon alfa-2a (40kDa) plus ribavirin in patients with HIV and hepatitis C virus co-infection. J Clin Virol. 2006 Aug; 36(4):283-91. PMID: 16765638.
      View in: PubMed
    28. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, S Sulkowski M, Torriani F, Dieterich DT, Thomas DL, Messinger D, Nelson M. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology. 2006 Jun; 43(6):1317-25. PMID: 16729309.
      View in: PubMed
    29. Schrier RD, Song MK, Smith IL, Karavellas MP, Bartsch DU, Torriani F, Garcia CR, Freeman WR. Intraocular viral and immune pathogenesis of immune recovery uveitis in patients with healed cytomegalovirus retinitis. Retina. 2006 Feb; 26(2):165-9. PMID: 16467672.
      View in: PubMed
    30. Currier JS, Kendall MA, Henry WK, Torriani F, Hodis HN. Response to: 'carotid intima-media thickness: assessment of sub-clinical atherosclerosis in HIV-infected patients'. AIDS. 2006 Jan 09; 20(2):311. PMID: 16511437.
      View in: PubMed
    31. Mathews WC, Caperna JC, Barber RE, Torriani F, Miller LG, May S, McCutchan JA. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr. 2005 Oct 01; 40(2):155-60. PMID: 16186732.
      View in: PubMed
    32. Aberg JA, Zackin RA, Brobst SW, Evans SR, Alston BL, Henry WK, Glesby MJ, Torriani F, Yang Y, Owens SI, Fichtenbaum CJ. A randomized trial of the efficacy and safety of fenofibrate versus pravastatin in HIV-infected subjects with lipid abnormalities: AIDS Clinical Trials Group Study 5087. AIDS Res Hum Retroviruses. 2005 Sep; 21(9):757-67. PMID: 16218799.
      View in: PubMed
    33. Currier JS, Kendall MA, Zackin R, Henry WK, Alston-Smith B, Torriani F, Schouten J, Mickelberg K, Li Y, Hodis HN. Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure. AIDS. 2005 Jun 10; 19(9):927-33. PMID: 15905673; PMCID: PMC1373680.
    34. Torriani F, Chung RT. Peginterferon alpha-2a improved the hepatitis C virologic response in concurrent HIV and chronic hepatitis C virus infections. ACP J Club. 2005 Jan-Feb; 142(1):A12; author reply A13. PMID: 15656540.
      View in: PubMed
    35. Mauss S, Valenti W, DePamphilis J, Duff F, Cupelli L, Passe S, Solsky J, Torriani F, Dieterich D, Larrey D. Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy. AIDS. 2004 Sep 03; 18(13):F21-5. PMID: 15316334.
      View in: PubMed
    36. Torriani F, Rodriguez-Torres M, Rockstroh JK, Lissen E, Gonzalez-García J, Lazzarin A, Carosi G, Sasadeusz J, Katlama C, Montaner J, Sette H, Passe S, De Pamphilis J, Duff F, Schrenk UM, Dieterich DT. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med. 2004 Jul 29; 351(5):438-50. PMID: 15282351.
      View in: PubMed
    37. El-Bradey MH, Cheng L, Song MK, Torriani F, Freeman WR. Long-term results of treatment of macular complications in eyes with immune recovery uveitis using a graded treatment approach. Retina. 2004 Jun; 24(3):376-82. PMID: 15187659; PMCID: PMC1378115.
    38. Cotter BR, Torriani F. Cardiovascular effects of antiretroviral therapy and noninvasive assessments of cardiovascular disease in HIV infection. Cardiovasc Toxicol. 2004; 4(3):281-6. PMID: 15470275.
      View in: PubMed
    39. Torriani F, Ribeiro RM, Gilbert TL, Schrenk UM, Clauson M, Pacheco DM, Perelson AS. Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) dynamics during HCV treatment in HCV/HIV coinfection. J Infect Dis. 2003 Nov 15; 188(10):1498-507. PMID: 14624375.
      View in: PubMed
    40. Song MK, Azen SP, Buley A, Torriani F, Cheng L, Chaidhawangul S, Ozerdem U, Scholz B, Freeman WR. Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis. Am J Ophthalmol. 2003 Oct; 136(4):696-702. PMID: 14516810.
      View in: PubMed
    41. Aberg JA, Williams PL, Liu T, Lederman HM, Hafner R, Torriani F, Lennox JL, Dube MP, MacGregor RR, Currier JS. A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group 393 Study Team. J Infect Dis. 2003 Apr 01; 187(7):1046-52. PMID: 12660918.
      View in: PubMed
    42. Lalezari J, Lindley J, Walmsley S, Kuppermann B, Fisher M, Friedberg D, Lalonde R, Matheron S, Nieto L, Torriani F, Van Syoc R, Sutton MA, Buhles W, Stempien MJ. A safety study of oral valganciclovir maintenance treatment of cytomegalovirus retinitis. J Acquir Immune Defic Syndr. 2002 Aug 01; 30(4):392-400. PMID: 12138345.
      View in: PubMed
    43. Kurup A, Torriani F. Therapy and Prevention of Cytomegalovirus Retinitis. Curr Infect Dis Rep. 2001 Aug; 3(4):371-377. PMID: 11470029.
      View in: PubMed
    Francesca's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _